共 134 条
- [1] Abshire T(2004)Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors J Thromb Haemost 2 899-909
- [2] Kenet G(2001)A cell-based model of haemostasis Thromb Haemost 85 958-965
- [3] Hoffman M(1997)Platelet activity of high dose factor VIIa is independent of tissue factor Br J Haematol 99 542-547
- [4] Monroe DM(2004)Recombinant factor VIIa: clinical applications for an intravenous haemostatic agent with broad-spectrum potential Expert Rev Cardiovasc Ther 2 661-674
- [5] Monroe DM(2004)Current concepts of hemostasis: implications for therapy Anesthesiology 100 885-893
- [6] Hoffman M(2004)Argatroban as anticoagulant in cardiopulmonary bypass in an infant and attempted reversal with recombinant activated factor VII Anesthesiology 101 1048-1049
- [7] Oliver JA(2001)Recombinant activated factor VII for adjunctive hemorrhage control in trauma J Trauma 51 431-439
- [8] Roberts HR(2004)Factor VIIa for correction of traumatic coagulopathy J Trauma 57 709-719
- [9] Carr ME(2005)Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double blind clinical trial Anesthesiology 102 269-275
- [10] Martin EJ(2005)Recombinant Factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients. A randomized, placebo-controlled, double-blind clinical trial J Trauma 59 8-18